These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9876570)
21. In vitro release of colchicine using poly(phosphazenes): the development of delivery systems for musculoskeletal use. Ibim SM; el-Amin SF; Goad ME; Ambrosio AM; Allcock HR; Laurencin CT Pharm Dev Technol; 1998 Feb; 3(1):55-62. PubMed ID: 9532600 [TBL] [Abstract][Full Text] [Related]
22. Materials and biological aspects of synthetic polymers in controlled drug release systems: problems and challenges. Bruck SD; Mueller EP Crit Rev Ther Drug Carrier Syst; 1988; 5(3):171-87. PubMed ID: 3060266 [TBL] [Abstract][Full Text] [Related]
23. [Recent trends in drug delivery systems using biomaterials]. Kurisawa M; Yui N Nihon Rinsho; 1996 Jul; 54(7):2004-11. PubMed ID: 8741703 [TBL] [Abstract][Full Text] [Related]
24. Microchips and controlled-release drug reservoirs. Staples M Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):400-17. PubMed ID: 20564466 [TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo demonstration of risperidone implants in mice. Rabin C; Liang Y; Ehrlichman RS; Budhian A; Metzger KL; Majewski-Tiedeken C; Winey KI; Siegel SJ Schizophr Res; 2008 Jan; 98(1-3):66-78. PubMed ID: 17765477 [TBL] [Abstract][Full Text] [Related]
31. Development of an in vitro dissolution method using microdialysis sampling technique for implantable drug delivery systems. Dash AK; Haney PW; Garavalia MJ J Pharm Sci; 1999 Oct; 88(10):1036-40. PubMed ID: 10514352 [TBL] [Abstract][Full Text] [Related]
32. [Bioabsorbable osteofixation devices]. Iera D; Haddad AJ; Sándor GK; Ashmmakhi N Ann Chir Plast Esthet; 2005 Dec; 50(6):723-32. PubMed ID: 16181721 [TBL] [Abstract][Full Text] [Related]
33. Nano, micro particulate and cosmetic delivery systems of polylactic acid: A mini review. Abu Hajleh MN; Al-Samydai A; Al-Dujaili EAS J Cosmet Dermatol; 2020 Nov; 19(11):2805-2811. PubMed ID: 32954588 [TBL] [Abstract][Full Text] [Related]
34. Implantable, polymeric systems for modulated drug delivery. Sershen S; West J Adv Drug Deliv Rev; 2002 Nov; 54(9):1225-35. PubMed ID: 12393303 [TBL] [Abstract][Full Text] [Related]
35. Implantable systems for drug delivery to the brain. Kaurav H; Kapoor DN Ther Deliv; 2017 Dec; 8(12):1097-1107. PubMed ID: 29125063 [TBL] [Abstract][Full Text] [Related]
37. Active drug release systems: current status, applications and perspectives. Kiryukhin MV Curr Opin Pharmacol; 2014 Oct; 18():69-75. PubMed ID: 25265597 [TBL] [Abstract][Full Text] [Related]
38. Sustained and controlled release of neuroactive substances in the CNS by encapsulation into implantable polymers. Peterson GM Neurobiol Aging; 1989; 10(5):639-40; discussion 648-50. PubMed ID: 2812244 [TBL] [Abstract][Full Text] [Related]
39. Controlled drug release from implantable matrices based on hydrophobic polymers. Di Colo G Biomaterials; 1992; 13(12):850-6. PubMed ID: 1457678 [TBL] [Abstract][Full Text] [Related]
40. Drug Release Kinetics from Nondegradable Hydrophobic Polymers Can Be Modulated and Predicted by the Glass Transition Temperature. Qian J; Berkland C Adv Healthc Mater; 2021 Jun; 10(12):e2100015. PubMed ID: 33987963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]